Achillion Pharmaceuticals, Inc. (ACHN)

Watch the video to learn about the probability of Achillion Pharmaceuticals, Inc. (ACHN) Chart Signal as of Sep 01, 2014

Hotstocked Precision will calculate the probabilities of Achillion Pharmaceuticals, Inc. (ACHN)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD
Recent Material Events for Achillion Pharmaceuticals, Inc.
Date Description
Nov 08, 2012 The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section,
Nov 08, 2012 The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section,
Aug 31, 2012 On August 30, 2012, the Company entered into a subscription agreement (the “Subscription Agreement”) with funds managed by QVT Financial LP relating to the issue and sale of an aggregate of 6,367,853 shares of the Company’s common stoc
Aug 08, 2012 On August 8, 2012, Achillion Pharmaceuticals, Inc. (the “Company”) announced its financial results for the fiscal quarter ended June 30, 2012. The full text of the press release issued in connection with the announcement is furnished as Exh
Aug 08, 2012 On August 8, 2012, Achillion Pharmaceuticals, Inc. (the “Company”) announced its financial results for the fiscal quarter ended June 30, 2012. The full text of the press release issued in connection with the announcement is furnished as Exh
Jun 28, 2012 Effective June 25, 2012, Achillion Pharmaceuticals, Inc. (the “Company”), entered into a letter agreement (the “Agreement”) with Dr. Elizabeth A. Olek, the former Senior Vice President and Chief Medical Officer of the Company, in
Jun 11, 2012 On June 10, 2012, Nicholas Simon, a Class I director and a member of the Compensation Committee of the Board of Directors, resigned from the Board of Directors of Achillion Pharmaceuticals, Inc. (the “Company”).
Jun 06, 2012 On June 3, 2012, Dr. Elizabeth A. Olek, the Senior Vice President and Chief Medical Officer of Achillion Pharmaceuticals, Inc. (the “Company”), provided notice of her intention to resign from the Company, effective June 18, 2012.
Mar 08, 2012 The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section,
Jan 17, 2012 On January 11, 2012, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of Achillion Pharmaceuticals, Inc. (the “Company”) authorized the payment of the remaining approximately one-half of the annu

Watch the video to learn about the probability of Achillion Pharmaceuticals, Inc. (ACHN) Chart Signal as of Sep 01, 2014

This free program will calculate the probabilities of Achillion Pharmaceuticals, Inc. (ACHN) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD